Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis

References

• Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. J Eur Acad Dermatol Venerol. 2007;21:606–619. PubMed PMID: 17447974; eng.
   PubMed Web of Science ®Google Scholar
• Durnian JM, Stewart RMK, Tatham R, et al. Cyclosporin-A associated malignancy. Clin Ophthalmol (Auckland, NZ). 2007;1:421–430. PubMed PMID: 19668519; eng.
   PubMedGoogle Scholar
• Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol. 2002;147:324–330. PubMed PMID: 12174106; eng.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375:2335–2348.
   PubMed Web of Science ®Google Scholar
• Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130–139.
   PubMed Web of Science ®Google Scholar
• Thaçi D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387:40–52.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Papp K, Poulin Y, et al. Topical tofacitinib for atopic dermatitis: a phase II a randomized trial. Br J Dermatol. 2016;175:902–911.
   PubMed Web of Science ®Google Scholar
• Schwartz DM, Kanno Y, Villarino A, et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2018;17:78–78. PubMed PMID: 29282366; eng.
   Web of Science ®Google Scholar
• Zimmermann M, Rind D, Chapman R, et al. Economic evaluation of dupilumab for moderate-to-severe atopic dermatitis: a cost-utility analysis. J Drugs Dermatol. 2018;17:750–756. PubMed PMID: 30005097; eng.
   PubMed Web of Science ®Google Scholar
• Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–349. PubMed PMID: 24813298; PubMed Central PMCID: PMCPMC4410179. eng.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. PubMed PMID: 19621072; PubMed Central PMCID: PMCPMC2707599. eng.
   PubMed Web of Science ®Google Scholar
• Ballester I, Silvestre J, Pérez-Crespo M, et al. Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients. Actas Dermo-Sifiliográficas. 2009;100:883–887.
   PubMedGoogle Scholar
• Benez A, Fierlbeck G. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil . Br J Dermatol. 2001;144:638–639.
   PubMed Web of Science ®Google Scholar
• Dias-Polak D, Bergman R, Avitan-Hersh E. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis. J Dermatolog Treat. 2019;30:49–51.
   PubMed Web of Science ®Google Scholar
• Grundmann-Kollmann M, Korting H, Behrens S, et al. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 1999;141:175.
   PubMed Web of Science ®Google Scholar
• Grundmann-Kollmann M, Podda M, Ochsendorf F, et al. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001;137:870–873.
   PubMed Web of Science ®Google Scholar
• Haeck IM, Knol MJ, ten Berge O, et al. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2011;64:1074–1084.
   PubMed Web of Science ®Google Scholar
• Hansen E, Buus S, Deleuran M, et al. Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 2000;143:1324–1326.
   PubMed Web of Science ®Google Scholar
• Hantash B, Fiorentino D. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. Arch Dermatol. 2006;142:109–116.
   PubMedGoogle Scholar
• Heller M, Shin HT, Orlow SJ, et al. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol. 2007;157:127–132. PubMed PMID: 17489974; eng.
   PubMed Web of Science ®Google Scholar
• Kurayev A, Gottlieb AB. Candida esophagitis associated with mycophenolate mofetil treatment of atopic dermatitis. J Drugs Dermatol. 2016;15:1267–1269. PubMed PMID: 27741346; eng.
   PubMed Web of Science ®Google Scholar
• Li J, Chong AH, Green J, et al. Mycophenolate use in dermatology: a clinical audit. Australas J Dermatol. 2013;54:296–302. PubMed PMID: 23574297; eng.
   PubMedGoogle Scholar
• Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol. 2007;32:23–27. PubMed PMID: 17059445; eng.
   PubMed Web of Science ®Google Scholar
• Neuber K, Schwartz I, Itschert G, et al. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 2000;143:385–391. PubMed PMID: 10951150; eng.
   PubMed Web of Science ®Google Scholar
• Nguyen RH, Cruz PD. Jr. Hepatitis due to mycophenolate mofetil used to treat atopic dermatitis and allergic contact dermatitis. Dermatitis. 2014;25:284–285. PubMed PMID: 25207697; PubMed Central PMCID: PMCPMC4163951. eng.
   PubMed Web of Science ®Google Scholar
• Satchell AC, Barnetson RS. Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate. Brit J Dermatol. 2000;143:202–203. PubMed PMID: 10886168; eng.
   PubMed Web of Science ®Google Scholar
• Tull TJ, Toma T, Menage HP. Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil. Clin Exp Dermatol. 2016;41:702–703. PubMed PMID: 27079159; eng.
   PubMed Web of Science ®Google Scholar
• van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, et al. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study. Brit J Dermatol. 2009;160:687–691. PubMed PMID: 19120337; eng.
   PubMed Web of Science ®Google Scholar
• Waxweiler WT, Agans R, Morrell DS. Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil. Pediatr Dermatol. 2011;28:689–694. PubMed PMID: 21967657; eng.
   PubMed Web of Science ®Google Scholar
• Ettenger R, Sarwal MM. Mycophenolate mofetil in pediatric renal transplantation. Transplantation. 2005;80:S201–S10. PubMed PMID: 16251853; eng.
   PubMed Web of Science ®Google Scholar
• Buratti S, Szer IS, Spencer CH, et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol. 2001;28:2103–2108. PubMed PMID: 11550982; eng.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112:1472–1477. PubMed PMID: 16061096; eng.
   PubMed Web of Science ®Google Scholar
• Mimouni D, Anhalt GJ, Cummins DL, et al. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139:739–742. PubMed PMID: 12810504; eng.
   PubMed Web of Science ®Google Scholar
• Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol. 2003;139:1121–1124. PubMed PMID: 12975151; eng.
   PubMedGoogle Scholar
• Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet (London, England). 1991;338:137–140. PubMed PMID: 1677063; eng.
   PubMed Web of Science ®Google Scholar
• Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet (London, England). 2006;367:839–846. PubMed PMID: 16530578; eng.
   PubMed Web of Science ®Google Scholar
• Reynolds NJ, Franklin V, Gray JC, et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet (London, England). 2001;357:2012–2016. PubMed PMID: 11438134; eng.
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Ho PL, Stablein DM, et al. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplantation. 2002;6:396–399. PubMed PMID: 12390426; eng.
   PubMed Web of Science ®Google Scholar
• Stern ST, Tallman MN, Miles KK, et al. Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats. Drug Metab Dispos. 2006;35:449–454. PubMed PMID: 17172313; eng.
   PubMed Web of Science ®Google Scholar